Selected vfa bio-articles in english language

The new biotech report describing the situation of medical biotechnology in Germany is now available. It was provided by The Boston Consulting Group for vfa bio. This yearly report is the only one recording all activities within medical biotechnology in Germany – ranging from startup to big companies. In addition to key economic data on medical biotechnology in Germany in 2017, the focus of this year’s report is on the production of biopharmaceuticals as well as on the benefit of biopharmaceuticals for patients with metabolic diseases.

Read on 

The new biotech report describing the situation of medical biotechnology in Germany is now available. It was provided by The Boston Consulting Group for vfa bio. This yearly report is the only one recording all activities within medical biotechnology in Germany – ranging from startup to big companies. In addition to key economic data on medical biotechnology in Germany in 2016, the focus of this year’s report is on oncology.

Read on 

The new biotech report describing the situation of medical biotechnology in Germany is now available. It was provided by The Boston Consulting Group for vfa bio. This yearly report is the only one recording all activities within medical biotechnology in Germany – ranging from startup to big companies.

Read on 

A brief summary of the key economic data in medical biotechnology in Germany, a ten-year comparison and seven assumptions on developments, which are likely to shape the biopharmaceutical industry over the course of the next ten years.

Read on